How relevant are the drug-drug interactions between antiretroviral boosted-based regimens and calcium channel blockers in real life?

Dario Cattaneo, Tiziana Formenti, Noemi Astuti, Paola Meraviglia, Annalisa Ridolfo, Cristina Gervasoni

Journal: The Journal of antimicrobial chemotherapy 2019;73(8):2271-2273

PMID: 29897531

Full Text on Ovid Technologies, Inc. View on PubMed

Abstract

Address: Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.; Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy.

DOI: 10.1093/jac/dky139

Link outs

Free resources

Medical:

https://medlineplus.gov/drugreactions.html

Other Literature Sources:

https://scite.ai/reports/29897531

Subscription / membership required

Full Text Sources:

MeSH Terms: Aged, Anti-Retroviral Agents, Calcium Channel Blockers, Cobicistat, Drug Interactions, Female, HIV Infections, Humans, Hypertension, Male, Middle Aged, Retrospective Studies, Ritonavir